...
首页> 外文期刊>Biochimica et Biophysica Acta. Gene Regulatory Mechanisms >Integration of genome-wide of Stat3 binding and epigenetic modification mapping with transcriptome reveals novel Stat3 target genes in glioma cells
【24h】

Integration of genome-wide of Stat3 binding and epigenetic modification mapping with transcriptome reveals novel Stat3 target genes in glioma cells

机译:整合全基因组Stat3结合和表观遗传修饰图谱与转录组揭示神经胶质瘤细胞中新的Stat3靶基因

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in many human tumors, including gliomas, and regulates the expression of genes implicated in proliferation, survival, apoptosis, angiogenesis and immune regulation. Only a small fraction of those genes has been proven to be direct STAT3 targets. In gliomas, STAT3 can play tumor suppressive or oncogenic roles depending on the tumor genetic background with target genes being largely unknown.Results: We used chromatin immunoprecipitation, promoter microarrays and deep sequencing to assess the genome-wide occupancy of phospho (p)-Stat3 and epigenetic modifications of H3K4me3 and H3ac in C6 glioma cells. This combined assessment identified a list of 1200 genes whose promoters have both Stat3 binding sites and epigenetic marks characteristic for actively transcribed genes. The Stat3 and histone markings data were also intersected with a set of microarray data from C6 glioma cells after inhibition of Jak2/Stat3 signaling. Subsequently, we found 284 genes characterized by p-Stat3 occupancy, activating histone marks and transcriptional changes. Novel genes were screened for their potential involvement in oncogenesis, and the most interesting hits were verified by ChIP-PCR and STAT3 knockdown in human glioma cells.Conclusions: Non-random association between silent genes, histone marks and p-Stat3 binding near transcription start sites was observed, consistent with its repressive role in transcriptional regulation of target genes in glioma cells with specific genetic background.
机译:背景:信号转导和转录激活因子3(STAT3)在许多人类肿瘤(包括神经胶质瘤)中被组成性激活,并调节与增殖,存活,凋亡,血管生成和免疫调节有关的基因的表达。这些基因中只有一小部分被证明是STAT3直接靶标。在神经胶质瘤中,STAT3可以发挥抑癌或致癌作用,具体取决于肿瘤的遗传背景,而靶基因在很大程度上未知。结果:我们使用染色质免疫沉淀,启动子​​微阵列和深度测序来评估全基因组磷酸(p)-Stat3的占有率C6胶质瘤细胞中H3K4me3和H3ac的表达和表观遗传修饰。这项综合评估确定了1200个基因的清单,这些基因的启动子同时具有Stat3结合位点和主动转录基因特有的表观遗传标记。抑制Jak2 / Stat3信号后,还将Stat3和组蛋白标记数据与来自C6胶质瘤细胞的一组微阵列数据相交。随后,我们发现了284个具有p-Stat3占用,激活组蛋白标记和转录变化特征的基因。筛选新基因可能参与肿瘤发生,并通过ChIP-PCR和STAT3敲低人脑胶质瘤细胞验证最有趣的命中。结论:沉默基因,组蛋白标记和转录开始附近p-Stat3结合之间的非随机关联观察到这些位点,与其在具有特定遗传背景的神经胶质瘤细胞中对靶基因的转录调控中的抑制作用相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号